| Closed |
SWOG-7510 |
Adjuvant Chemotherapy for Patients with Locally Advanced Adenocarcinoma of the Large Bowel |
8/8/1975 |
8/20/1980 |
|
|
Published
|
| Closed |
SWOG-7804 |
Adjuvant Chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin-C (FAM) Versus Surgery Alone for Patients with Locally Advanced Gastric Adenocarcinoma |
3/10/1978 |
8/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-8066 |
Adjuvant Intrahepatic Chemotherapy with Mitomycin-C and 5-FU Combined with Hepatic Radiation in High Risk Patients with Carcinoma of the Colon |
8/25/1980 |
3/3/1983 |
|
|
Published
|
| Closed |
SWOG-8591(NCI Intergroup #0035) |
An Evaluation of Levamisole Alone or Levamisole plus 5-Fluorouracil as Surgical Adjuvant Treatment for Resectable Adenocarcinoma of the Colon |
1/14/1985 |
10/1/1987 |
|
|
Published
|
| Closed |
SWOG-7940/44 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
9/23/1980 |
6/4/1981 |
|
|
|
| Closed |
SWOG-7940/45 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
6/4/1981 |
5/5/1982 |
|
|
|
| Closed |
SWOG-9000 |
Biomarkers of Colorectal Cancer Prognosis |
2/15/1991 |
9/15/1993 |
67% |
|
Published
|
| Closed |
S0518 |
CARCINOID Ph III depot octreotide + either interferon alpha or bevacizumab |
12/1/2007 |
9/1/2012 |
100% |
|
Published
|
| Closed |
SWOG-9041 |
Chemoprevention of Recurrent Adenomas and Second Primary Colorectal Carcinoma, A Phase III Pilot Study |
2/1/1993 |
4/15/1999 |
100% |
|
Published
|
| Closed |
SWOG-8424 |
Chemotherapy in Metastatic Colorectal Carcinoma with 5-FU and Cis-Platinum |
12/7/1984 |
5/1/1987 |
|
|
Published
|
| Closed |
SWOG-8390 |
Chemotherapy of Gastric Cancer with 5-Fluorouracil (5-FU) and Folinic Acid |
3/16/1984 |
3/1/1988 |
|
|
Published
|
| Closed |
SWOG-8305 |
Chemotherapy of Metastatic Colorectal Carcinoma with 5-FU and Folinic Acid |
5/27/1983 |
3/16/1984 |
|
|
Published
|
| Closed |
SWOG-9118 |
Chemotherapy with FAMTX in Gastric Cancer or FMTX in Colorectal Cancer: Assessment of Pharmacodynamics with Magnetic Resonance Spectroscopy, Cellular Biochemical Pharmacology, and Cellular Pathology,… |
11/15/1991 |
11/15/1995 |
18% |
|
Published
|
| Closed |
S0809 |
Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT |
12/1/2008 |
10/1/2012 |
100% |
|
Published
|
| Closed |
SWOG-8901 |
Clinical Trial of the Most Active Drugs Selected by Clonogenic Assay to be Administered by the Intrahepatic Arterial Route for Colorectal Cancer Metastatic to the Liver |
9/1/1990 |
10/15/1991 |
5% |
|
|
| Closed |
SWOG-9419 |
COLORECTAL |
3/15/1995 |
8/15/2001 |
|
|
|
| Closed |
S9635 |
COLORECTAL |
4/1/1998 |
9/15/2000 |
49% |
|
Published
|
| Closed |
S9923 |
COLORECTAL |
6/1/2000 |
8/1/2001 |
100% |
|
Published
|
| Closed |
S0030 |
COLORECTAL |
2/1/2003 |
2/1/2005 |
48% |
|
Published
|
| Closed |
S0303 |
COLORECTAL |
4/1/2004 |
9/1/2004 |
2% |
|
|
